Ads
related to: acute myeloid leukemia treatment- Dosing & Administration
Learn about dosing and
administration now
- Mechanism of Action
Learn about the MOA
of a new treatment option
- Dosing & Administration
Search results
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
FOX21 Colorado Springs· 4 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 10 hours agoStockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock ...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
WROC Rochester· 4 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
Syrian first lady Asma al-Assad diagnosed with leukemia, president's office says
Fox News· 6 days agoThe first lady of Syria, Asma al-Assad, has been diagnosed with leukemia, according to the nation's...
MD Anderson Research Highlights for May 21, 2024 | Newswise
Newswise· 6 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 3 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Syrian first lady diagnosed with leukemia
China Daily· 6 days agoSyrian First Lady Asma al-Assad has been diagnosed with acute myeloid leukemia, a type of blood cancer, the Syrian presidency said in ...
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 4 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 4 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal...
Centers for Disease Control and Prevention· 4 days agoWe describe an underrecognized Scedosporium spp. and Lomentospora prolificans vascular tropism requiring specific management of which clinicians should be aware.
Ads
related to: acute myeloid leukemia treatment